Nucleic Acid Aptamers Market Size is valued at USD 217.3 Mn in 2023 and is predicted to reach USD 732.5 Mn by the year 2031 at a 16.7% CAGR during the forecast period for 2024-2031.
Nucleic acid aptamers are concise, individual strands of DNA or RNA that have a strong affinity for certain targets, such as proteins or tiny molecules. They are chosen via a procedure known as SELEX and are recognized for their stability, strong attraction, and minimal immune response. Aptamers find applications in diagnostics, therapies, and targeted drug delivery, providing benefits such as facile synthesis and the capability to operate in diverse settings.
The rising disposable income, improvements in aptamer creation technology, and more funding for businesses and academic institutions are all elements propelling the market forward. Additionally, more and more medical fields are looking to these tiny molecules for a variety of reasons, including the many benefits they provide over well-established antibodies.
The competitive advantages of nucleic acid aptamers have drawn the attention of many researchers, who have recently made improvements in drug delivery, target cell death, and drug purification. Researchers are motivated to develop new nucleic acid aptamers because of their small molecular size, low immunogenicity, cheap manufacturing cost, and fewer side effects in comparison to antibodies. This could lead to industry expansion. The ongoing development of novel and improved nucleic acid aptamers is propelling market expansion.
However, due to the high costs, stringent regulatory constraints, and a general lack of knowledge of nucleic acid treatments among both patients and healthcare professionals, the nucleic acid aptamers industry is expected to slow down market growth. The rapid advancement of research and development, the increased focus on the efficacy of RNA aptamers, and the surge in investment and interest in nucleic acid-based treatments for infectious diseases were all beneficial effects of the COVID-19 pandemic for the nucleic acid aptamers business. Furthermore, the demand for nucleic acid aptamers is expected to rise due to innovative treatments receiving substantial funding from pharmaceutical firms and governments.
Competitive Landscape
Some Major Key Players In The Nucleic Acid Aptamers Market:
- Aptagen Labs
- Aptamer Group
- Base Pair Biotechnologies
- NeoVentures Biotechnology Inc.
- Aptamer Sciences, Inc.
- SomaLogic Operating Co., Inc.
- AptaTargets SL.
- Aptus Biotech S.L
- NOVAPTECH
- Kaneka Eurogentec S.A.
- Aptadel Therapeutics
- RIBOMIC
- Other Market Players
Market Segmentation:
The nucleic acid aptamers market is segmented based on type, application, indication, and end-user. By type, the market is segmented into DNA aptamer, RNA aptamer, and XNA aptamer. By the application, the market is segmented into drug delivery, anti-viral therapy, pathogen recognition, disease recognition, stem cell markers, and others. By indication, the market is segmented into viral infection, cancer, ophthalmology, and others. By end-user, the market is segmented into biopharmaceutical companies, diagnostic centres, CROs, and others.
Based On The Type, The DNA Aptamer Nucleic Acid Aptamers Segment Is Accounted As A Major Contributor To The Nucleic Acid Aptamers Market.
The DNA aptamer in the nucleic acid aptamers category is expected to lead with a significant global market share in 2023 because it’s very stable, easy to change, and cheap to make. Its demand is further driven by its adaptability in numerous applications, such as pharmaceuticals, biosensors, and diagnostics. Further, DNA aptamers are becoming more popular as a result of rising investment in R&D and improvements in DNA synthesis technologies, which is growing the worldwide market.
Biopharmaceutical Companies Segment To Witnessed A Rapid Growth.
The biopharmaceutical companies segment is predicted to grow rapidly in the nucleic acid aptamers market because there is a growing need for novel diagnostic and therapeutic solutions and a growing investment in R&D. Aptamers are appealing for drug discovery and development due to their many advantages, including high specificity, stability, and cost-effectiveness. Nucleic acid aptamers are in high demand in this market because of the increasing fascination with targeted therapeutics and customized medicine, which is growing the biopharmaceutical companies segment growth.
In The Region, The North American Nucleic Acid Aptamers Market Holds A Significant Revenue Share.
The North American nucleic acid aptamers market is expected to report the highest market revenue share in the near future because of the growing popularity of cutting-edge diagnostic and treatment options, improved healthcare infrastructure, and substantial funding for biotechnology research. The market is also being propelled even higher by a strong pharmaceutical industry and government programs that are encouraging. In addition, the Asia-Pacific region is expected to grow quickly in the global nucleic acid aptamers market because due to the increasing need for cutting-edge diagnostic and therapeutic solutions, the expansion of biotechnology research, and the expansion of healthcare infrastructure investments, which is growing the market demand in this area.
Nucleic Acid Aptamers Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 217.3 Mn |
|
Revenue Forecast In 2031 |
USD 732.5 Mn |
|
Growth Rate CAGR |
CAGR of 16.7% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, Application, Indication and End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Aptagen Labs, Aptamer Group, Base Pair Biotechnologies, NeoVentures Biotechnology Inc., Aptamer Sciences, Inc., SomaLogic Operating Co., Inc., AptaTargets SL., and Aptus Biotech S.L. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
